who r lonzo..., page-4

Hi Vinn,

In addition to the tax breaks ( which are so helpful in building the future cash flow's of the company), having another look at the article below ( & the reference to "significant incentives") makes me think that there is more than just tax that the Singaporian Goverment will be using to attract the worlds largest stem cell company. Goverment Grants would be another benefit and incentive for MSB. No doubt if there are grants available, MSB management would be all over it ( all in my opinion)

http://www.theaustralian.com.au/business-old/industry-sectors/offshore-lure-for-stem-cell-firm-mesoblast/story-e6frg97f-1226065210400

Also great move by MSB to have the right to purchase the manufacturing facility from Lonzo ( CEO really thinking of the bigger picture and TEVA).

Reading The Australian last Thursday 29/9/2011, I noted MSB was listed as ASX No 84 by Market Cap (now #3 Biotech behind CSL & Resmed). My understanding is MSB has been under ASX 100 for a little while.

IMO, whilst not S&P ASX100, MSB's ranking in the top ASX100 stocks (by market capitalisation), speaks volumes for the world-class management, the MPC technology and the confidence the company is gaining from fund managers.

Yep, I agree Vinny - with 12 ongoing aplications , solid stock to have in current market.

Cheers to all Holders and always DYOR before making any decisions.